JSPR – jasper therapeutics, inc. - class a (US:NASDAQ)
Stock Stats
News
Jasper Therapeutics GAAP EPS of -$0.32 beats by $0.48 [Seeking Alpha]
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab [Yahoo! Finance]
Jasper Therapeutics (JSPR) is now covered by UBS Group AG. They set a "neutral" rating and a $1.50 price target on the stock.
Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference [Yahoo! Finance]
Form 8-K Jasper Therapeutics, For: Mar 30
Form 10-K Jasper Therapeutics, For: Dec 31
Form SCHEDULE 13G Jasper Therapeutics, Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Form SCHEDULE 13D/A Jasper Therapeutics, Filed by: Carlyle Group Inc.
Form SCHEDULE 13G Jasper Therapeutics, Filed by: GOLDMAN SACHS GROUP INC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.